Smarter drug decisions,
powered by AI
Vibe Bio’s VibeOne platform is the AI decision infrastructure for biopharma BD enabling faster, better decisions.
The VibeOne BD impact
8x
Faster asset diligence
75%
SME workloads reduction
50%
More assets identified
Why VibeOne?
The future of drug strategy uses AI
Achieve greater agility, fresh perspectives, and sharper precision — even when expert resources are limited.
AI-powered insights, validated
Identify the full landscape to target, track changes, and triage assets with the highest potential.
Investing for cures and impact
Vibe Bio invests in founders committed to finding cures for rare and overlooked diseases.
The AI buying guide for BD&L executives
Watch this webinar with Alok Tayi, PhD, Co-Founder and CEO of Vibe Bio to learn how to evaluate and choose AI solutions to achieve real results. Walk through a practical, executive-level framework for evaluating AI solutions for BD&L teams.
Bring speed and scalability to BD decisions
Contact us to learn how to streamline your due diligence drug decisions with AI or about our venture fund.